Vanrx Market Share Analysis for April 2026

cytiva is a provider of leading life sciences brands such as äkta, amersham, hyclone, mabselect and whatman.

Health > Biotechnology and Pharmaceuticals

Domainvanrx.com

Year Founded2007

Employees51 - 200

Annual Revenue$15M - $25M

Vanrx

Vanrx (including company regionals)

vanrx.com

See more website traffic and engagement information

Vanrx Revenue up to April 2026 is 15M - 25M

revenue generated by Vanrx top domains

Vanrx top domains revenue over 3 years

Revenue for Vanrx top domains

vanrx.com15M - 25M

See more with Sales Intelligence

Total visits to Vanrx's top domains

Understand Vanrx market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Vanrx's top domains

Analyze Vanrx engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Vanrx's top domains

See how Vanrx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Vanrx top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Vanrx

These are the website technologies, by industry, used by Vanrx top domains

Advertising (9)

DoubleClick

Audio Video Media (3)

YouTube

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Vanrx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVanrx Pharmasystems Inc. sold assets to Cytiva on Jan 25th '22.Cytiva had acquired the aseptic business from Canada-based Vanrx in early 2021, which completed its biomanufacturing workflow and enables the company to offer solutions from “idea to injection.”

NewsDanaher acquired Vanrx Pharmasystems Inc. on Feb 1st '21.Danaher Corporation (NYSE: DHR ) DHR acquired Canada-based Vanrx Pharmasystems in February 2021, while Swift Biosciences was added to its portfolio in first-quarter 2021.

NewsCytivalifesciences acquired Vanrx Pharmasystems Inc. on Feb 1st '21.Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges with reduced risk and increased speed to patients.